BRIEF published on 08/12/2026 at 15:30, 30 days 7 hours ago The Vanguard Group Discloses Positions in Picton Property Income Limited Form 8.3 Takeover Code Securities Disclosure Vanguard Group Picton Property
PRESS RELEASE published on 08/12/2026 at 15:29, 30 days 7 hours ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.55% stake in Spire Healthcare Group plc. Purchase of 11,386 1p ordinary securities at 2.30 GBP per unit Securities Vanguard Group Spire Healthcare Purchase Stake
PRESS RELEASE published on 08/12/2026 at 15:27, 30 days 7 hours ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses 5.65% stake in SEGRO plc. Public disclosure under Rule 8.3 of the Takeover Code Disclosure The Vanguard Group Rule 8.3 Takeover Code SEGRO PLC
PRESS RELEASE published on 08/12/2026 at 15:27, 30 days 7 hours ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses 5.30% stake in LondonMetric Property plc and 0.92% in Schroder Real Estate Investment Trust Limited as of 11 August 2026 LondonMetric Property Plc Relevant Securities The Vanguard Group Stake Disclosure Schroder Real Estate Investment Trust Limited
PRESS RELEASE published on 08/12/2026 at 15:25, 30 days 7 hours ago Form 8.3 - The Vanguard Group, Inc.: Bodycote plc The Vanguard Group, Inc. discloses a 5.43% stake in Bodycote plc as of 11 August 2026. Details of the holdings are provided in Form 8.3 under Rule 8.3 of the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure Bodycote PLC
PRESS RELEASE published on 08/12/2026 at 15:25, 30 days 7 hours ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses 3.47% stake in Picton Property Income Limited as per Form 8.3 filing Form 8.3 Financial Filing Vanguard Group Stake Disclosure Picton Property Income Limited
BRIEF published on 08/11/2026 at 15:30, 1 month ago The Vanguard Group, Inc. Discloses Position in Prologis, Inc. Form 8.3 Takeover Code Vanguard Group SEC Disclosure Prologis Inc.
BRIEF published on 08/11/2026 at 15:30, 1 month ago Vanguard's Interest in JTC plc Disclosed Takeover Code Vanguard Group Shareholding Disclosure Public Company JTC Plc
BRIEF published on 08/11/2026 at 15:28, 1 month ago Vanguard Discloses Stake in Beazley plc Form 8.3 Takeover Code Vanguard Group Stake Disclosure Beazley Plc
BRIEF published on 08/11/2026 at 15:27, 1 month ago The Vanguard Group Discloses Stake in Rotork plc Investment Strategy Takeover Code Vanguard Group Stock Disclosure Rotork Plc
Published on 09/11/2026 at 21:25, 1 hour 29 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 5 hours 54 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 15:25, 7 hours 29 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 7 hours 54 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 22:15, 39 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 43 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 3 hours 9 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 4 hours 38 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 15 hours 54 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 15 hours 54 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 3 hours ago Availability of the 2026 Interim Financial Report
